DHEA Therapy: A Clinical Guide for Providers

Written by Empire Medical Training Editorial Team

Medically reviewed by Betsy Greenleaf, DO Board-Certified OB/GYN & Urogynecologist; Empire Director of Anti-Aging

Updated June 2026 ·11 min read

DHEA (dehydroepiandrosterone) is one of the most abundant steroid hormones in the human body, yet it is also one of the most misunderstood. Patients encounter it as an over-the-counter supplement marketed for energy, libido, and “anti-aging,” while clinicians know it primarily as an upstream precursor in the steroid cascade — the raw material the body draws on to make testosterone and estrogen. Using DHEA well means understanding both faces of it: where it sits in hormone physiology, and where the marketing outruns the evidence.

This guide situates DHEA within the broader field of hormone replacement therapy and is written for clinicians who want an accurate, practical overview. It is clinical education, not medical advice, and nothing here should be read as a treatment recommendation, protocol, or dosing instruction.

What is DHEA?

DHEA is a steroid hormone produced predominantly by the adrenal glands, with smaller contributions from the gonads and, in the brain, local synthesis. To place it correctly, it helps to recall how every steroid hormone begins. As Dr. Betsy Greenleaf frames it in Empire's hormone course, cholesterol is the common precursor to all of them. In a relaxed, parasympathetic state, cholesterol travels down the pathway into pregnenolone and progesterone, and from there the body builds the downstream hormones — including DHEA, testosterone, and the estrogens.

That position in the pathway is why DHEA earns its nickname as the “mother hormone.” It is not primarily a hormone with one dedicated job; it is a reservoir. DHEA itself has relatively limited direct biological activity. Its clinical importance comes from what tissues convert it into: depending on local enzyme activity and the body's needs, DHEA can be processed into testosterone and, through aromatization, into estrogen. In effect, DHEA is the body's flexible supply of sex-hormone building blocks.

It also circulates largely in a sulfated storage form, DHEA-sulfate (DHEA-S), which is far more stable in the bloodstream and is the form clinicians most often measure. Because DHEA is so abundant and so far upstream, small shifts in adrenal output can ripple downstream into the sex-hormone picture — a reason it deserves attention rather than dismissal.

Why DHEA declines with age

DHEA levels follow a predictable arc. They rise through adolescence, peak in the twenties, and then fall steadily decade by decade, so that by later life circulating DHEA is a fraction of its youthful peak. This age-related decline is one of the most reliable patterns in endocrine aging, and it parallels the broader hormonal slowdown clinicians see across the lifespan. As Dr. Greenleaf notes, as men age and testosterone naturally declines, that drop is commonly associated with lower DHEA levels as well — the two tend to fall together because they share the same upstream pathway.

Age, however, is not the only driver, and this is where the course's physiology becomes clinically useful. The adrenal gland sits at the intersection of sex-hormone production and the stress response. Under stress, the body prioritizes cortisol, the survival hormone needed in short bursts. The problem in modern life, Greenleaf explains, is that many patients are stuck in stress mode, chronically straining that pathway. When the demand for cortisol is relentless, precursors that would otherwise flow toward sex hormones get diverted — in her words, the raw material is “stolen to make cortisol.” In practice she often sees this signature directly on lab dials: a flattened cortisol curve alongside a low DHEA, the fingerprint of an adrenal system running on chronic stress.

The takeaway for providers is that a low DHEA is rarely a finding in isolation. It usually sits inside a larger story — age, chronic stress, and the state of the whole steroid cascade — and interpreting it well means reading that context rather than reacting to a single number. The cortisol side of this picture is explored in our companion guide on adrenal and cortisol health.

Studied benefits — and what the evidence really shows

DHEA is marketed for a long list of benefits, and this is exactly where clinicians need to be careful. The honest summary is that the evidence is mixed. Some patients report genuine improvement; the controlled-trial data are inconsistent, and many of the most heavily promoted claims are modest, population-specific, or simply unproven.

The areas most commonly studied include:

• Energy and well-being — some patients describe improved energy and mood, particularly those starting from genuinely low levels, but results across trials are inconsistent and the effect is not reliable enough to promise.
• Mood — there is signal in some studies, especially in the context of low baseline DHEA or adrenal insufficiency, but it is not a substitute for proper evaluation and treatment of mood disorders.
• Libido and sexual function — plausible given DHEA's conversion into testosterone and estrogen, and reported by some patients, though the data are far from definitive.
• Body composition — claims about fat loss and lean-mass gains are popular but weakly supported; any effect appears small and is easily overstated.

One application stands on firmer ground than the general anti-aging marketing: vaginal DHEA for the genitourinary symptoms of menopause is an FDA-approved, evidence-supported use, distinct from the broad systemic-benefit claims. Outside of specific indications like that, the responsible framing is the one Empire teaches: DHEA can be a reasonable, individualized tool in the right patient, but providers should set realistic expectations and avoid selling it as a cure-all. Overpromising on DHEA erodes the credibility that good hormone practice depends on.

DHEA in the hormone cascade

To use DHEA intelligently, a provider has to see it as one node in a connected network rather than a standalone pill. Dr. Greenleaf walks through this directly in the course: starting from cholesterol, the pathway moves into pregnenolone, then progesterone, and from there progesterone is processed into DHEA, then into testosterone, and testosterone can cross over into estrogen through aromatization. DHEA sits squarely in the middle of that chain — downstream of progesterone, upstream of the sex hormones.

This is the single most important concept on the page, because it explains both the appeal and the risk of DHEA. The appeal: supplying more precursor can support downstream production of testosterone and, by extension, estrogen, which is why some patients feel the effects of DHEA primarily as androgenic or estrogenic effects rather than anything DHEA-specific. The risk follows from the same fact: because hormones convert into one another, giving DHEA is never “just DHEA.” You are feeding a cascade, and the destination depends on the patient's own enzyme activity and metabolism.

Greenleaf makes the clinical consequence explicit. Because these hormones interconvert, she emphasizes that when you supplement DHEA in a woman, you have to think about the whole downstream picture — including protecting the uterus, since DHEA can ultimately contribute to estrogenic activity. This is why DHEA is woven into a complete protocol in the course, not handed out in isolation, and why understanding the cascade is the prerequisite to dosing it.

Testing and candidacy

The standard laboratory measure is DHEA-sulfate (DHEA-S), preferred over DHEA itself because the sulfated form is more stable across the day and less prone to the moment-to-moment fluctuation that makes a single random DHEA level hard to interpret. As Dr. Greenleaf cautions when reviewing patient panels, timing and context matter enormously with adrenal hormones — a lone reading taken at the wrong time can paint a misleading picture, which is part of why DHEA-S is the more dependable index.

But a number on a page is not a diagnosis. In the course, Greenleaf reads DHEA-S alongside the cortisol curve, testosterone, estradiol, and sex-hormone binding globulin (SHBG) — never alone. SHBG is a particularly important modifier: when it runs high, it binds up circulating hormones and can make other levels look artificially low, so DHEA-S has to be interpreted in the context of the binding proteins and the rest of the cascade. A low DHEA-S in a chronically stressed patient with a flat cortisol curve tells a very different story than the same number in someone else.

Good candidacy, then, is less about hitting a threshold and more about the whole clinical pattern: symptoms consistent with hormonal decline, a lab picture that fits, and a patient appropriately screened for the safety concerns below. The structured approach to building and interpreting a full panel — which labs to order, how to read them together, and how DHEA fits into the decision — is taught directly in Empire's course.

Safety considerations

DHEA is sold over the counter in the United States, which can create a false impression that it is trivial. It is not. Because it converts into testosterone and estrogen, DHEA carries the safety profile of the hormones it becomes.

The most common practical issue is androgenic effects. As DHEA is converted toward testosterone, patients — women especially — can develop acne, oily skin, or unwanted hair growth, and these are dose-related signals to watch for and respond to. The deeper concern is hormone-sensitive conditions: because DHEA ultimately feeds estrogen and testosterone production, it raises the same cautions as other sex-hormone therapy in patients with, or at elevated risk for, hormone-sensitive cancers such as certain breast and prostate cancers. These patients require careful evaluation, and in many cases DHEA is inappropriate.

A specific point Dr. Greenleaf stresses in the course: in women with a uterus, estrogen, testosterone, and DHEA are not recommended without appropriate protection, precisely because of the interconversion described above — DHEA can contribute to unopposed estrogenic effect on the endometrium. This is a non-negotiable safety principle, not a stylistic preference.

The honest bottom line: DHEA is a real hormone with real downstream effects, and it should be tested, dosed, and monitored under clinical supervision — not started casually because it sits on a shelf next to the vitamins.

How providers train to use DHEA

Because DHEA is inseparable from the rest of the steroid cascade, using it competently means understanding the whole system — not memorizing a single dose. The clinical skill set is specific: reading DHEA-S in context, recognizing the cortisol-steal pattern, selecting candidates, monitoring for androgenic and hormone-sensitive risks, and integrating DHEA into a complete bioidentical hormone protocol rather than prescribing it in isolation.

Empire's curriculum is built around exactly that kind of practical judgment, taught by Dr. Greenleaf through real patient panels and case walk-throughs. It situates DHEA within the broader science of bioidentical hormone replacement and connects it to the hands-on hormone pellet training that providers take to build or expand a hormone-optimization practice responsibly.